Thomas Bures

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

PVLA

Current role

CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Palvella Therapeutics, Inc. (PVLA)	Senior Vice President and Chief Financial Officer	$400,155	$80,031	—	$241,536	—	$7,315	$729,037
2022	Palvella Therapeutics, Inc. (PVLA)	Senior Vice President and Chief Financial Officer	$381,100	—	—	$444,183	$106,708	$12,200	$944,191
2021	Palvella Therapeutics, Inc. (PVLA)	Senior Vice President and Chief Financial Officer	$370,000	—	—	$243,044	$148,000	$11,600	$772,644
2020	Palvella Therapeutics, Inc. (PVLA)	Vice President, Finance	$283,250	—	—	$154,038	$65,856	$11,400	$514,544
2019	Palvella Therapeutics, Inc. (PVLA)	Vice President, Finance	$257,500	—	—	$152,938	$66,242	—	$476,680

No earnings-call appearances or filed executive changes recorded yet.